Haisco Pharmaceutical Group Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2024: USD -41.31 M

Haisco Pharmaceutical Group Co., Ltd. Net Cash Used For Investing Activities is USD -41.31 M for the year ending December 31, 2024, a -23.46% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Haisco Pharmaceutical Group Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2023 was USD -53.97 M, a -31.01% change year over year.
  • Haisco Pharmaceutical Group Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -78.23 M, a -276.30% change year over year.
  • Haisco Pharmaceutical Group Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD 44.38 M, a -151.80% change year over year.
  • Haisco Pharmaceutical Group Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -85.67 M, a 15.88% change year over year.
Key Data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Depreciation And Amortization Dividends Paid